Terms: = Colorectal cancer AND MALAT1, PRO1073, 378938, Q9UHZ2 AND Prognosis
19 results:
1. IL-2RG as a possible immunotherapeutic target in CRC predicting poor prognosis and regulated by miR-7-5p and miR-26b-5p.
Gharib E; Rejali L; Piroozkhah M; Zonoobi E; Nasrabadi PN; Arabsorkhi Z; Baghdar K; Shams E; Sadeghi A; Kuppen PJK; Salehi Z; Nazemalhosseini-Mojarad E
J Transl Med; 2024 May; 22(1):439. PubMed ID: 38720389
[TBL] [Abstract] [Full Text] [Related]
2. CD95 promotes stemness of colorectal cancer cells by lncRNA malat1.
Gao C; Jia K; Fang J; Zhu X; Hu J; Zhang Y; Jiang J; Yu X; Wang D; Gu H; Chen Z
Life Sci; 2024 Feb; 338():122394. PubMed ID: 38159593
[TBL] [Abstract] [Full Text] [Related]
3. malat1 in colorectal cancer: Its implication as a diagnostic, prognostic, and predictive biomarker.
Cervena K; Vodenkova S; Vymetalkova V
Gene; 2022 Nov; 843():146791. PubMed ID: 35961438
[TBL] [Abstract] [Full Text] [Related]
4. Associations of malat1 and its functional single nucleotide polymorphisms with cancer.
Cao L; Yan G; Yu S; Li F; Su Z; Hou X; Xiao J; Tian T
Pathol Res Pract; 2022 Aug; 236():153988. PubMed ID: 35759938
[TBL] [Abstract] [Full Text] [Related]
5. Long Noncoding RNA malat1 Promotes colorectal cancer Progression by Acting as a ceRNA of miR-508-5p to Regulate RAB14 Expression.
Zhang C; Yao K; Zhang J; Wang C; Wang C; Qin C
Biomed Res Int; 2020; 2020():4157606. PubMed ID: 33344634
[TBL] [Abstract] [Full Text] [Related]
6. Integration analysis of long non-coding RNA (lncRNA) role in tumorigenesis of colon adenocarcinoma.
Poursheikhani A; Abbaszadegan MR; Nokhandani N; Kerachian MA
BMC Med Genomics; 2020 Jul; 13(1):108. PubMed ID: 32727450
[TBL] [Abstract] [Full Text] [Related]
7. MicroRNA Binding Site Polymorphisms of the Long-Chain Noncoding RNA
Yang Q; Zheng W; Shen Z; Huang G; Yang G
Genet Test Mol Biomarkers; 2020 May; 24(5):239-248. PubMed ID: 32349546
[No Abstract] [Full Text] [Related]
8. JMJD2C promotes colorectal cancer metastasis via regulating histone methylation of malat1 promoter and enhancing β-catenin signaling pathway.
Wu X; Li R; Song Q; Zhang C; Jia R; Han Z; Zhou L; Sui H; Liu X; Zhu H; Yang L; Wang Y; Ji Q; Li Q
J Exp Clin Cancer Res; 2019 Oct; 38(1):435. PubMed ID: 31665047
[TBL] [Abstract] [Full Text] [Related]
9. Long Noncoding RNAs as Prognostic Markers for colorectal cancer in Saudi Patients.
Siddique H; Al-Ghafari A; Choudhry H; AlTurki S; Alshaibi H; Al Doghaither H; Alsufiani H
Genet Test Mol Biomarkers; 2019 Aug; 23(8):509-514. PubMed ID: 31328973
[No Abstract] [Full Text] [Related]
10. Long non-coding RNA polymorphisms and prediction of response to chemotherapy based on irinotecan in patients with metastatic colorectal cancer.
Lampropoulou DI; Aravantinos G; Katifelis H; Lazaris F; Laschos K; Theodosopoulos T; Papadimitriou C; Gazouli M
Cancer Biomark; 2019; 25(2):213-221. PubMed ID: 31045514
[TBL] [Abstract] [Full Text] [Related]
11. malat1 sponges miR-106b-5p to promote the invasion and metastasis of colorectal cancer via SLAIN2 enhanced microtubules mobility.
Zhuang M; Zhao S; Jiang Z; Wang S; Sun P; Quan J; Yan D; Wang X
EBioMedicine; 2019 Mar; 41():286-298. PubMed ID: 30797712
[TBL] [Abstract] [Full Text] [Related]
12. lncRNAs in Non-Malignant Tissue Have Prognostic Value in colorectal cancer.
Thiele JA; Hosek P; Kralovcova E; Ostasov P; Liska V; Bruha J; Vycital O; Rosendorf J; Opattova A; Horak J; Kralickova M; Vodicka P; Pitule P
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30205577
[TBL] [Abstract] [Full Text] [Related]
13. Chronic oxymatrine treatment induces resistance and epithelial‑mesenchymal transition through targeting the long non-coding RNA malat1 in colorectal cancer cells.
Xiong Y; Wang J; Zhu H; Liu L; Jiang Y
Oncol Rep; 2018 Mar; 39(3):967-976. PubMed ID: 29328404
[TBL] [Abstract] [Full Text] [Related]
14. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
[TBL] [Abstract] [Full Text] [Related]
15. Differentially expressed long non-coding RNAs and the prognostic potential in colorectal cancer.
Li Q; Dai Y; Wang F; Hou S
Neoplasma; 2016; 63(6):977-983. PubMed ID: 27596298
[TBL] [Abstract] [Full Text] [Related]
16. malat1 might be a predictive marker of poor prognosis in patients who underwent radical resection of middle thoracic esophageal squamous cell carcinoma.
Cao X; Zhao R; Chen Q; Zhao Y; Zhang B; Zhang Y; Yu J; Han G; Cao W; Li J; Chen X
Cancer Biomark; 2015; 15(6):717-23. PubMed ID: 26406400
[TBL] [Abstract] [Full Text] [Related]
17. Long Noncoding RNA MALAT-1 Can Predict Metastasis and a Poor prognosis: a Meta-Analysis.
Zhu L; Liu J; Ma S; Zhang S
Pathol Oncol Res; 2015 Sep; 21(4):1259-64. PubMed ID: 26159858
[TBL] [Abstract] [Full Text] [Related]
18. High expression of lncRNA malat1 suggests a biomarker of poor prognosis in colorectal cancer.
Zheng HT; Shi DB; Wang YW; Li XX; Xu Y; Tripathi P; Gu WL; Cai GX; Cai SJ
Int J Clin Exp Pathol; 2014; 7(6):3174-81. PubMed ID: 25031737
[TBL] [Abstract] [Full Text] [Related]
19. Long non-coding RNA malat1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2 complex.
Ji Q; Zhang L; Liu X; Zhou L; Wang W; Han Z; Sui H; Tang Y; Wang Y; Liu N; Ren J; Hou F; Li Q
Br J Cancer; 2014 Aug; 111(4):736-48. PubMed ID: 25025966
[TBL] [Abstract] [Full Text] [Related]
